Continuation of deferiprone therapy in patients with mild neutropenia may not lead to a more severe drop in neutrophil count-Reference-Cited by-同舟云学术

Continuation of deferiprone therapy in patients with mild neutropenia may not lead to a more severe drop in neutrophil count

Published:2014-01-30 Issue:4 Volume:92 Page:337-340
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

El-Beshlawy Amal M.¹,El-Alfy Mohsen S.²,Sari Teny T.³,Chan Lee L.⁴,Tricta Fernando⁵

Affiliation:

1. Hematology Department; Pediatric Hospital; Cairo University; Cairo Egypt

2. Children Hospital; Ain Shams University; Cairo Egypt

3. Cipto Mangunkusumo Hospital; Jakarta Indonesia

4. University of Malaya; Kuala Lumpur Malaysia

5. ApoPharma Inc.; Toronto ON Canada

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12241/fullpdf

Reference10 articles.

1. Idiosyncratic drug-induced agranulocytosis: update of an old disorder;Andres;Eur J Intern Med,2006

2. Ferriprox® (Deferiprone) Summary of Product Characteristics (SmPC) http://ec.europa.eu/health/documents/community-register/html/h108.htm

3. Bertola U Collell M Piga A Visconti RM Cohen A Neutropenia in homozygous b-thalassemic patients on desferrioxamine (DFO) treatment Proceedings of the 8th International Conference on Oral Chelation in the Treatment of Thalassemia and Other Diseases Corfu, Greece 1997 90

4. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis;Pennell;Blood,2006

5. The safety, tolerability, and efficacy of a liquid formulation of deferiprone in young children with transfusional iron overload;El Alfy;J Pediatr Hematol Oncol,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges of Iron Chelation in Thalassemic Children;Thalassemia Reports;2024-02-01

2. Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years;Blood Advances;2023-02-21

3. Neutropenia and Life-threatening Agranulocytosis Among Children With β-Thalassemia Treated With Oral Iron Chelators in a Community With Background of Ethnic Neutropenia;Journal of Pediatric Hematology/Oncology;2019-12-23

4. Combination Oral Chelation in Adult Patients With Transfusion-dependent Thalassemia and High Iron Burden;Journal of Pediatric Hematology/Oncology;2019-01

5. Long-term safety of deferiprone treatment in children from the Mediterranean region with beta-thalassemia major: the DEEP-3 multi-center observational safety study;HAEMATOLOGICA;2018